A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs
Condition: Breast Cancer Intervention: Drug: Palbociclib Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Conditions: Celiac Disease; Coeliac Disease Interventions: Drug: KAN-101; Drug: Placebo Sponsors: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs
Condition: Breast Cancer Intervention: Drug: Palbociclib Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Conditions: Celiac Disease; Coeliac Disease Interventions: Drug: KAN-101; Drug: Placebo Sponsors: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs
Condition: Breast Cancer Intervention: Drug: Palbociclib Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Conditions: Celiac Disease; Coeliac Disease Interventions: Drug: KAN-101; Drug: Placebo Sponsors: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs
Condition: Breast Cancer Intervention: Drug: Palbociclib Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Conditions: Celiac Disease; Coeliac Disease Interventions: Drug: KAN-101; Drug: Placebo Sponsors: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs
Condition: Breast Cancer Intervention: Drug: Palbociclib Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco
Condition: COVID-19 Drug Treatment Intervention: Drug: Nirmatrelvir/Ritonavir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Varients in Healthy Individuals
Conditions: SARS-CoV-2 Infection; COVID-19 Intervention: Biological: BNT162b2 (Omi XBB.1.5) Sponsors: BioNTech SE; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco
Condition: COVID-19 Drug Treatment Intervention: Drug: Nirmatrelvir/Ritonavir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Varients in Healthy Individuals
Conditions: SARS-CoV-2 Infection; COVID-19 Intervention: Biological: BNT162b2 (Omi XBB.1.5) Sponsors: BioNTech SE; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco
Condition: COVID-19 Drug Treatment Intervention: Drug: Nirmatrelvir/Ritonavir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Varients in Healthy Individuals
Conditions: SARS-CoV-2 Infection; COVID-19 Intervention: Biological: BNT162b2 (Omi XBB.1.5) Sponsors: BioNTech SE; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
